MacroGenics shareholders approve all proposals at 2026 annual meeting, including 1.25M share increase to equity plan

MACROGENICS INC

All four Class I director nominees elected: Scott Koenig, Federica O'Brien, Eric Risser (over 26M votes for each).
Ratified Ernst & Young as independent auditor for FY2026 with 36.7M votes for, 40,552 against.
Advisory say-on-pay approved with 26.6M for, 526k against, 195k abstain.
Amendment to 2023 Equity Incentive Plan approved, increasing authorized shares by 1,250,000.
Voter turnout ~58%; broker non-votes of 9.4M shares on director and advisory proposals.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.